Savara Inc. (SVRA)
NASDAQ: SVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 4.88 0.00%
SVRA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.00B
- EPS (TTM)
- -$0.58
- Dividend yield
- None
- 52-week range
- 3.34 – 7.01
- Day range
- 4.69 – 5.05
- Volume / Avg
- 2.41M / 1.81M
- Beta
- —
- Shares outstanding
- 205.46M
- Next earnings
- Nov 11, 2026
52-week range
SVRA stock today
On Oct 7, SVRA ended the session at $4.88, adding $0.23 (4.95%), versus the S&P 500's 0.22% decline. At this level, SVRA sits in the middle of its 52-week range of $3.34 to $7.01: 30.3% below the high, set on Dec 12, 2025 and 46.1% above the low. SVRA is down 19.1% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 42.3%.
Savara has posted a net loss over the last twelve months (EPS of -$0.58), so its P/E ratio is not meaningful. Savara's next earnings report is expected on Nov 11, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Savara
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 11, 2026
Savara peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SPTXSeaport Therapeutics Inc. | 17.93 | +3.22% | $959.80M | vs SVRA |
| KURAKura Oncology Inc. | 10.67 | +1.33% | $949.21M | vs SVRA |
| ANROAlto Neuroscience Inc. | 23.52 | -0.72% | $922.97M | vs SVRA |
| MLTXMoonLake Immunotherapeutics Class A | 10.77 | -1.64% | $916.60M | vs SVRA |
| AKTSAktis Oncology Inc. | 18.00 | +0.78% | $1.00B | vs SVRA |
| PCRXPacira BioSciences Inc. | 25.20 | +1.78% | $1.00B | vs SVRA |
| ANLAdlai Nortye Group Ltd. ADR | 14.05 | -2.84% | $904.79M | vs SVRA |
| RIGLRigel Pharmaceuticals Inc. | 47.99 | +4.08% | $896.45M | vs SVRA |
Indexes, lists and sector
Largest Health Care stocks
Savara stock FAQ
What is Savara's stock price today?
SVRA last traded at $4.88 as of Oct 7, 4:00 PM EDT, up 4.95% on the day. Prices are delayed at least 15 minutes.
When is Savara's next earnings date?
Savara is expected to report earnings on Wednesday, November 11, 2026.
What is the SVRA 52-week high?
The 52-week high for SVRA is $7.01 and the 52-week low is $3.34. The stock is currently 30.3% below its high.